Hawkeye Group, a leading health and wellness company, is excited to unveil ClenchAlert, a groundbreaking solution aimed at addressing awake teeth clenching and grinding—a condition that frequently results in discomfort and pain in the face, neck, and back. Available from…
The 2024 National Diabetes Care Survey revealed a remarkable trend: the use of cellular-enabled glucose meters among people with Type 2 diabetes has surged by 57.6% compared to 2023. This annual survey, which has been tracking Type 2 diabetes care…
SurgeonCheck has launched an innovative surgeon recommendation tool. By visiting www.surgeoncheck.com, patients can easily find personalized suggestions for top surgeons in their area, powered by an extensive analysis of clinical data from 10.3 billion claims and 148 million procedures. The…
Researchers from City of Hope®, a leading cancer research and treatment organization in the United States, presented new findings at the 2024 ASH conference in San Diego, California, from December 7 to 10. Known for its comprehensive cancer center in…
Swisslog Healthcare, a leader in robotic medication management solutions, has partnered with BD, a global medical technology company, to co-market an innovative solution for hospital pharmacies. This collaboration integrates Swisslog’s advanced robotics with BD’s top-tier inventory management and workflow software,…
MiSalud Health, a prominent digital health platform offering affordable, same-day bilingual telehealth consultations (Spanish/English) in the U.S. and Mexico, has announced the appointment of co-founder Bismarck Lepe as CEO. Lepe steps into the role as Cindy Blanco transitions to lead…
Lantern Pharma Inc. (NASDAQ: LTRN), an AI-driven company developing targeted cancer therapies through its proprietary RADR® AI platform, announced today the enrollment and dosing of the first patient in Taiwan for its Phase 2 HARMONIC™ clinical trial. The trial is…
Four new studies on the Breast Cancer Index (BCI) test will be presented at the 2024 San Antonio Breast Cancer Symposium (SABCS). Among these, preliminary data will be shared exploring the potential of the BCI test to identify postmenopausal women…
Celltrion announced today that Health Canada has approved Omlyclo™, a biosimilar referencing Xolair®. Omlyclo™ is now approved for the treatment of adults and adolescents with chronic idiopathic urticaria (CIU), also known as chronic spontaneous urticaria (CSU), as well as for…
Intelliguard, a leading provider of RFID-enabled medication management and data-intelligence solutions, has announced a strategic partnership with Codonics, a global leader in healthcare technology focused on patient safety. This collaboration integrates Intelliguard’s Mira Care Station with Codonics’ Safe Label System…
DNAnexus, Inc., a leader in precision health data platforms, and Panomics, Inc., specializing in AI-powered omics data management and discovery for biopharma, have announced a strategic collaboration. This partnership will deliver biopharma organizations a comprehensive solution for multi-omics data management…
MaaT Pharma will host a KOL webinar on December 17th, 2024, to discuss the data and the unmet medical need in acute Graft-versus-Host Disease (aGvHD) – Register here. Key Results: MaaT Pharma (EURONEXT: MAAT), a clinical-stage biotechnology company specializing in…
